ReviewNpj biosensing2026
Biosensors in dental, oral and craniofacial applications.
Review in Npj biosensing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral and dental health is an important indicator and determinant of an individual's overall well-being. Untreated oral diseases can lead to severe systemic complications. Monitoring the oral environment and identifying biochemical and physiological patterns associated with disease states, such as periodontitis, gingivitis, caries, and oral cancers, is essential for early diagnosis and effective intervention. This review evaluates the current clinical needs in biochemical and physiological monitoring for oral healthcare and state-of-the-art biosensors capable of continuous analyte measurement. We surveyed the relevant biomarkers for common oral and dental diseases in patients compared to healthy controls. The design and performance of recent biosensing devices for these target analytes are reviewed and evaluated. For biochemical sensing, we found intraoral biosensors for high-abundance small molecules, such as ions and metabolites, have advanced significantly in recent years. However, robust sensing technologies for low-abundance analytes, including cytokines and other inflammatory biomarkers, remain limited and require further development in sensing mechanisms, bio-interfaces, and device integration. For physiological sensing, particularly the measurement of forces in tooth movement, recent developments in force sensor technologies have substantially improved measurement accuracy over traditional techniques. Despite these advancements, current platforms still face limitations in achieving long-term, real-time monitoring of mechanical conditions within the oral cavity due to challenges related to biocompatibility and device miniaturization. In conclusion, while notable progress has been made in biosensing for oral applications, continued research in device integration with clinical practices is essential to realize robust and clinically deployable biosensor systems that can advance precision oral healthcare.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.